What TransMedics Group, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 1 | 2 |
| Sells | 0 | 12 |
| Total trades | 2 | 35 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 1,336 | 177,932 |
| Disposed | 18,000 | 57,875 |
| Net activity | −16,664 | +120,057 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Weill David | Director | Sep 11 | Open-market buy · P | +1,336 | $81.63 | +$109K | 16,392 |
| Tobin James R | Director | Aug 17 | Gift · G | −18,000 | — | — | 0 |
| Hassanein Waleed H | President & CEO | Jul 10 | Grant / award · A | +49,669 | — | — | 171,093 |
| Hernandez Gerardo | Chief Financial Officer | Jul 10 | Grant / award · A | +17,246 | — | — | 31,935 |
| Corcoran Nicholas | See remarks | Jul 10 | Grant / award · A | +11,727 | — | — | 41,558 |
| Gunderson Thomas James | Director | Jun 15 | Open-market sale · S | −9,624 | $75.06 | −$722K | 16,642 |
| Gunderson Thomas James | Director | Jun 15 | Exercise / conversion · M | +19,285 | $2.21 | +$42.6K | 26,266 |
| Kania Edwin M Jr | Director | May 20 | Grant / award · A | +2,922 | — | — | 263,732 |
| Tobin James R | Director | May 20 | Grant / award · A | +2,922 | — | — | 6,981 |
| Gunderson Thomas James | Director | May 20 | Grant / award · A | +2,922 | — | — | 6,981 |
| Basile Edward M | Director | May 20 | Grant / award · A | +2,922 | — | — | 5,788 |
| Raines Merilee | Director | May 20 | Grant / award · A | +2,922 | — | — | 6,981 |
| Weill David | Director | May 20 | Grant / award · A | +2,922 | — | — | 15,056 |
| Lovell Stephanie | Director | May 20 | Grant / award · A | +2,922 | — | — | 5,788 |
| Forsyth Matthew S. | See Remarks | May 19 | Grant / award · A | +15,409 | — | — | 15,409 |
| Hernandez Gerardo | Chief Financial Officer | Mar 04 | Open-market sale · S | −5,912 | $147.21 | −$870K | 14,689 |
| Hernandez Gerardo | Chief Financial Officer | Mar 04 | Exercise / conversion · M | +5,912 | $69.84 | +$413K | 20,601 |
| Hernandez Gerardo | Chief Financial Officer | Mar 04 | Open-market sale · S | −1,324 | $147.21 | −$195K | 14,689 |
| Hernandez Gerardo | Chief Financial Officer | Mar 04 | Exercise / conversion · M | +1,324 | $77.12 | +$102K | 16,013 |
| Lovell Stephanie | Director | Mar 04 | Open-market sale · S | −1,193 | $149.62 | −$178K | 2,866 |
Loading...
